Premier Alternatives

Unravel Biosciences

Medford, MA · Founded 2021 · Privately Held (backing)

Developer of an artificial intelligence-driven systems biology platform designed to discover and clinically validate therapeutic targets for complex diseases. Unravel Biosciences is based in Medford, MA and was founded in 2021. It was valued at $18 million at its early-stage round in Sep 2025, the last priced event on record. It has raised $4.5 million across 2 recorded rounds; the latest was a $500,000 seed round in Feb 2023.

PMV mark · valuation
$18.0M
Oct 2026
Priced at
its early-stage round
Sep 2025
Total raised
$4.5M
Last round
Seed Round
Feb 2023

Unravel Biosciences key facts

as of Oct 2026
  • Developer of an artificial intelligence-driven systems biology platform designed to discover and clinically validate therapeutic targets for complex diseases.
  • Unravel Biosciences is valued at approximately $18.0M as of Oct 2026, set at its early-stage round, Sep 2025; nothing has traded since, per PrivateMarketView’s mark.
  • It has raised $4.5M across 2 recorded rounds; the latest was Seed Round ($500K) in Feb 2023.
  • Notable investors include Creative Destruction Lab, BoxOne Ventures, Solari Capital, Harvard University, Bacchus Venture Capital — 12 tracked in total.
  • Unravel Biosciences has filed 2 Form Ds with the SEC since 2021, most recently Mar 2023 ($500K sold to 4 investors).
  • Status: Privately Held (backing).
PrivateMarketView mark
LOW confidence
$18.0M

Valued at $18.0M at its early-stage round, Sep 2025. Nothing has traded since.

set by its last priced roundas of Oct 2026question about this number?
Free account
More of Unravel Biosciences with a free account
  • ·The complete investor list: 12 names
  • ·Watch Unravel Biosciences: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Unravel Biosciences funding rounds

2 rounds
Feb 2023Seed Round$500KSEC filing▮
Jul 2021Seed Round$500KSEC filing▮
Full funding history →

Unravel Biosciences valuation

Unravel Biosciences was valued at $18 million at its early-stage round in Sep 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Unravel Biosciences raised?

Unravel Biosciences has raised $4.5 million in total; 2 of its rounds are on record. The largest on record was a $500,000 seed round in Feb 2023.

Unravel Biosciences has filed 2 Form Ds with the SEC since 2021, most recently in Mar 2023 ($500,000 sold to 4 investors).

Unravel Biosciences investors

12 investors are on record for Unravel Biosciences, including Creative Destruction Lab, BoxOne Ventures, Solari Capital and Harvard University. The seed round in Feb 2023 drew 4 investors.

About Unravel Biosciences

Developer of an artificial intelligence-driven systems biology platform designed to discover and clinically validate therapeutic targets for complex diseases. The company's platform offers Living Molecular Twin modeling, proprietary BioNAV-based computation, and primary transcriptomics-driven disease simulation, enabling biotechnology and pharmaceutical researchers to predict therapeutic response and accelerate data-driven drug discovery and clinical validation.

Sector
Healthcare
HQ
Medford, MA, United States
Founded
2021
Employees
14
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.